The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Vitamin C Derivative Promising Option for OA

Vitamin C Derivative Promising Option for OA

August 24, 2015 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Clinical_500x270Several studies have suggested that antioxidants, such as N-acetyl cysteine (NAC) and procyanids, are able to attenuate the development of instability-induced osteoarthritis (OA) in mice. Moreover, vitamin C has been shown to promote the synthesis of type II collagen and aggrecan in cartilage explants from guinea pigs. These results have led investigators to suggest that vitamin C might have beneficial effects on cartilage degeneration.

You Might Also Like
  • Can Lubricating Joints Prevent Osteoarthritis?
  • Adenosine Treatment Promotes Cartilage Homeostasis
  • Hyaluronidase 2 May Play an Important Role in OA Progression
Also By This Author
  • Mirtazapine Ineffective for Fibromyalgia

Masato Koike, MD, PhD, professor and chairman of the Department of Cell Biology and Neuroscience in the Juntendo University Graduate School of Medicine in Tokyo, Japan, and colleagues published the results of their mouse study in Scientific Reports online on June 25.1 They found that mitochondrial superoxide appears to play a pivotal role in the development and progression of osteoarthritis. They began their research with normal 20-week-old, C57BL/6 mice and performed surgical destabilization of the medial meniscus (DMM). This procedure induced abnormal loading in the chondrocytes of the knee cartilage. The investigators then evaluated the gene expression of several superoxide-degrading enzyme genes (Sod1, Sod2 and Sod3).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We discovered that abnormal loading significantly elevated mitochondrial superoxide generation and down-regulated the Sod2 expression in wild-type chondrocytes from the DMM side compared with the sham side before the appearance of obvious cartilage degeneration in vivo, suggesting a negative correlation between the mitochondrial superoxide leak and Sod2 decline,” wrote the researchers.

Paraquat (PQ) is a mitochondrial superoxide inducer at I26. The investigators treated the mice with PQ and were able to induce mitochondrial superoxide generation at complex I26 and significantly suppress Sod2 expression in wild-type chondrocytes from the DMM side when compared to chondrocytes from the sham side. The suppression occurred even prior to obvious cartilage degeneration in vivo.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We have, for the first time, demonstrated that SOD2 loss in chondrocytes accelerated cartilage degeneration during aging and under an instability murine model,” emphasized the authors in their discussion.

They then investigated the expression of OA-related genes in PQ-treated mice. The results suggested that PQ treatment suppressed the gene expression of antioxidant enzymes, including Sod2. This then resulted in impaired extracellular matrix (ECM) metabolism.

To further investigate the OA phenotypes of cartilage and chondrocytes, the investigators created chondrocyte-specific, Sod2-deficient mice that had mitochondrial superoxide overproduction and dysfunction. They examined Sod2 loss in chondrocytes-accelerated cartilage degeneration during aging and found that the Sod2-deficient mice did have accelerated cartilage degeneration relative to control littermates.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“We selected a stable, permeable and less toxic vitamin C derivative to suppress mitochondrial superoxide generation in chondrocytes in vivo,” explained the authors. When the investigators injected the permeable antioxidant L-ascorbyl 2-phosphate 6-palmitate (APPS) into the intra-articular space, they were able to effectively suppress mechanical-loading-induced mitochondrial superoxide generation, as well as cartilage degeneration in the mice. The authors concluded their paper by suggesting that mitochondrial superoxide balance may be a promising therapeutic target for cartilage degeneration. They also propose further investigation into the effects of an intra-articular injection of a vitamin C derivative to reduce cartilage degeneration.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

  1. Koike M, Nojiri H, Ozawa Y, et al. Mechanical overloading causes mitochondrial superoxide and SOD2 imbalance in chondrocytes resulting in cartilage degeneration. Sci Rep. 2015 Jun 25;5:11722. doi: 10.1038/srep11722

Pages: 1 2 | Multi-Page

Filed Under: Conditions, Osteoarthritis Tagged With: cartilage, chondrocyte, osteoarthritis (OA), Vitamin C

You Might Also Like:
  • Can Lubricating Joints Prevent Osteoarthritis?
  • Adenosine Treatment Promotes Cartilage Homeostasis
  • Hyaluronidase 2 May Play an Important Role in OA Progression
  • Low Levels of Vitamin D3 May Increase OA Pain

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)